BackPacific Shuanglin Bio-pharmacy , Ltd. Overview

Pacific Shuanglin Bio-pharmacy , Ltd. Receivables

Pacific Shuanglin Bio-pharmacy , Ltd.'s receivables is $810M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$813.14M
↑ 4.79% YoYΔ $37.17M vs prior year quarter

Peer trimmed avg / median

Loading

Pacific Shuanglin Bio-pharmacy , Ltd. Receivables History

Loading

Pacific Shuanglin Bio-pharmacy , Ltd. vs. peers: Receivables Comparison

Loading

Pacific Shuanglin Bio-pharmacy , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pacific Shuanglin Bio-pharmacy , Ltd. (000403.SZ) FAQ

The latest receivables for 000403.SZ is $810M as of September 2026. That compares with $780M in the prior-year period — up 4.8% year over year. Investors often review this figure alongside Pacific Shuanglin Bio-pharmacy , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 000403.SZ's receivables moved from $780M to $810M — a 4.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pacific Shuanglin Bio-pharmacy , Ltd.'s operating scale or balance-sheet position.

A receivables figure of $810M for 000403.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 000403.SZ's receivables ($810M), review year-over-year change from $780M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Pacific Shuanglin Bio-pharmacy , Ltd.'s receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.